SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Real World Evidence in Life Sciences: What Happens After Clinical Trials?

International Institute for Analytics Discussion Summary

About this paper

In the pharmaceutical industry, the overarching goal is to bring drugs and devices to market faster that improve health outcomes for patients. But what happens once those drugs are in the market and clinical trials conclude? Real world evidence (RWE) can provide deep insight into how a drug is actually used and how it performs in the real world with all its variety of settings and circumstances. This paper explores how RWE is transforming drug development, the new opportunities and benefits from RWE, and the challenges that remain. 

About SAS

SAS is the leader in analytics. Through innovative analytics, business intelligence and data management software and services, SAS helps customers at more than 80,000 sites make better decisions faster. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.

 

Have a SAS profile? To complete this form automatically Oturum Aç

*
*
*
*
 
*
*
 
 

Back to Top